SCHEMBL8768367

SCHEMBL8768367

COc1ccc(C(C)(C)O[C]=O)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
CA2 P00918 3/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
ACHE P22303 1/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11757932 0.79 L3MBTL1 (0.43) CASP1HSD17B10L3MBTL1CA2CA12
SCHEMBL636001 0.78 VCP (0.43) CASP1HSD17B10L3MBTL1ACHETSHR
SCHEMBL11164918 0.75 TSHR (0.47) CASP1HSD17B10L3MBTL1CA2CA12
SCHEMBL29436012 0.74 CA2 (0.50) CASP1HSD17B10CA2CA12CA1
SCHEMBL179467 0.74 CA2 (0.50) CASP1HSD17B10CA2CA12CA1
SCHEMBL27784134 0.74 TSHR (0.46) L3MBTL1CA2CA12CA1CA7
SCHEMBL14660462 0.72 CA2 (0.48) CASP1HSD17B10L3MBTL1CA2CA12
SCHEMBL11063020 0.72 ALDH1A1 (0.47) HSD17B10L3MBTL1CA2CA12CA1
SCHEMBL601662 0.72 TSHR (0.52) CASP1HSD17B10L3MBTL1CA2CA12
SCHEMBL9620 0.72 ALDH1A1 (0.44) CA2CA1CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4416871-A Inhibition by peptides of tolerance to and physical dependence on morphine THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1983-11-22 US claimed
US-RE30496-E Tripeptide derivatives with central nervous system activity and preparation thereof AYERST, MCKENNA & HARRISON, LTD. (CA) 1981-01-27 US claimed
EP-0016136-A1 INHIBITION BY PEPTIDES OF TOLERANCE TO AND DEPENDENCE ON MORPHINE University of Illinois Foundation (US) 1980-10-01 EP claimed
WO-1980000216-A1 INHIBITION BY PEPTIDES OF TOLERANCE TO AND DEPENDENCE ON MORPHINE UNIV ILLINOIS (US) 1980-02-21 WO claimed
US-4018912-A Tripeptide derivatives with central nervous system activity and preparation thereof AYERST MCKENNA AND HARRISON LTD. (CA) 1977-04-19 US claimed
EP-0792283-A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH CHIRON CORPORATION (US) 1997-09-03 EP disclosed
WO-1996015143-A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH CHIRON CORPORATION (US) 1996-05-23 WO disclosed
US-RE30496-E Tripeptide derivatives with central nervous system activity and preparation thereof AYERST, MCKENNA & HARRISON, LTD. (CA) 1981-01-27 US disclosed
US-4018912-A Tripeptide derivatives with central nervous system activity and preparation thereof AYERST MCKENNA AND HARRISON LTD. (CA) 1977-04-19 US disclosed